Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 13 studies | 27% ± 11% | |
peripheral blood | 10 studies | 32% ± 15% | |
intestine | 8 studies | 23% ± 8% | |
brain | 6 studies | 28% ± 7% | |
uterus | 5 studies | 30% ± 13% | |
bone marrow | 4 studies | 33% ± 22% | |
eye | 4 studies | 18% ± 2% | |
breast | 4 studies | 21% ± 4% | |
pancreas | 3 studies | 46% ± 23% | |
kidney | 3 studies | 22% ± 0% | |
lymph node | 3 studies | 21% ± 1% | |
prostate | 3 studies | 35% ± 8% | |
liver | 3 studies | 28% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 8044.55 | 459 / 459 | 100% | 148.97 | 1118 / 1118 |
esophagus | 100% | 7370.77 | 1445 / 1445 | 100% | 144.89 | 183 / 183 |
intestine | 100% | 7597.57 | 966 / 966 | 100% | 135.75 | 527 / 527 |
ovary | 100% | 9461.72 | 180 / 180 | 100% | 159.41 | 430 / 430 |
prostate | 100% | 7182.61 | 245 / 245 | 100% | 80.70 | 502 / 502 |
stomach | 100% | 5927.32 | 359 / 359 | 100% | 143.08 | 286 / 286 |
uterus | 100% | 7801.72 | 170 / 170 | 100% | 108.01 | 459 / 459 |
thymus | 100% | 7784.47 | 653 / 653 | 100% | 124.79 | 604 / 605 |
lung | 100% | 6440.80 | 576 / 578 | 100% | 104.21 | 1154 / 1155 |
liver | 100% | 4707.78 | 226 / 226 | 100% | 88.61 | 404 / 406 |
brain | 99% | 4086.05 | 2623 / 2642 | 100% | 77.99 | 705 / 705 |
kidney | 100% | 4565.17 | 89 / 89 | 99% | 89.23 | 888 / 901 |
pancreas | 100% | 3870.34 | 328 / 328 | 98% | 89.24 | 175 / 178 |
bladder | 100% | 6449.19 | 21 / 21 | 98% | 89.73 | 493 / 504 |
skin | 100% | 9406.77 | 1809 / 1809 | 97% | 71.28 | 460 / 472 |
adrenal gland | 100% | 4461.02 | 258 / 258 | 95% | 61.42 | 219 / 230 |
adipose | 100% | 6357.41 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 11057.45 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 4344.08 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 80.74 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 39.88 | 1 / 1 |
muscle | 99% | 4946.17 | 795 / 803 | 0% | 0 | 0 / 0 |
heart | 98% | 4956.11 | 847 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 95% | 47.11 | 76 / 80 |
lymph node | 0% | 0 | 0 / 0 | 86% | 42.18 | 25 / 29 |
peripheral blood | 84% | 3407.41 | 782 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0002327 | Biological process | immature B cell differentiation |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0003714 | Molecular function | transcription corepressor activity |
GO_0046872 | Molecular function | metal ion binding |
Gene name | IRF2BP2 |
Protein name | Interferon regulatory factor 2-binding protein 2 (IRF-2-binding protein 2) (IRF-2BP2) |
Synonyms | |
Description | FUNCTION: Acts as a transcriptional corepressor in a IRF2-dependent manner; this repression is not mediated by histone deacetylase activities . Represses the NFAT1-dependent transactivation of NFAT-responsive promoters . Acts as a coactivator of VEGFA expression in cardiac and skeletal muscles . Plays a role in immature B-cell differentiation . . |
Accessions | Q7Z5L9 ENST00000366609.4 [Q7Z5L9-1] ENST00000366610.7 [Q7Z5L9-2] |